The Brain Prize is an evergreen venture capital fund that focuses on investing in life science companies. Their main goal is to support the translation and commercialization of groundbreaking science, particularly in the field of novel medicines. By doing so, they aim to generate an attractive financial return while also contributing to the growth of the Danish biotech ecosystem.

With a portfolio of companies such as Akamis Bio, DYSIS Medical, VarmX, and Enterome, The Brain Prize has been successful in identifying scientific breakthroughs and developing new medical solutions. They believe in building long-term sustainable businesses and are committed to fostering collaborations with exceptional research talent. Supported by The Lundbeck Foundation, The Brain Prize is dedicated to promoting healthcare science research, with a particular emphasis on the brain.

Through their annual distribution of more than DKK 500 million, they aim to make significant contributions to the advancement of medical knowledge and innovation. For those interested in learning more, The Brain Prize provides updates, investment team information, and contact details on their website